| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2020 | MIGRA-THERAPEUTICS, LLC | 1750 HAYGOOD DR NE | ATLANTA | GA | 30322-1119 | DEKALB | USA | R41CA247165 | Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents | 000 | 1 | NIH | 2/1/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $842,157 ) |
| | 2023 | 2023 | MIGRA-THERAPEUTICS LLC | 58 EDGEWOOD AVE NE | ATLANTA | GA | 30303-2921 | FULTON | USA | R44CA246827 | Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy | 000 | 3 | NIH | 7/20/2023 | $841,919 |
| | 2023 | 2019 | MIGRA-THERAPEUTICS, LLC | 1750 HAYGOOD DR NE | ATLANTA | GA | 30322-1119 | DEKALB | USA | R43CA246827 | Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy | 000 | 1 | NIH | 5/12/2023 | $238 |
|
| Issue Date FY: 2022 ( Subtotal = $934,200 ) |
| | 2022 | 2022 | MIGRA-THERAPEUTICS, LLC | 58 EDGEWOOD AVE NE | ATLANTA | GA | 30303-2921 | FULTON | USA | R44CA246827 | Translational Development of a Targeted and Stroma-penetrating Nanoparticle Drug for Pancreatic Cancer Therapy | 000 | 2 | NIH | 9/15/2022 | $934,438 |
| | 2022 | 2020 | MIGRA-THERAPEUTICS, LLC | 58 EDGEWOOD AVE NE | ATLANTA | GA | 30303-2921 | FULTON | USA | R41CA247165 | Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents | 000 | 1 | NIH | 6/3/2022 | $0 |
| | 2022 | 2020 | MIGRA-THERAPEUTICS, LLC | 58 EDGEWOOD AVE NE | ATLANTA | GA | 30303-2921 | FULTON | USA | R41CA247165 | Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents | 001 | 1 | NIH | 6/3/2022 | $0 |
| | 2022 | 2019 | MIGRA-THERAPEUTICS LLC | 58 EDGEWOOD AVE NE | ATLANTA | GA | 30303-2921 | FULTON | USA | R43CA246827 | Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy | 000 | 1 | NIH | 6/30/2022 | -$238 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2019 | MIGRA-THERAPEUTICS, LLC | 3175 PRESIDENTIAL DR SUITE B | ATLANTA | GA | 30340-3907 | DEKALB | USA | R43CA246827 | Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy | 000 | 1 | NIH | 2/18/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $330,363 ) |
| | 2020 | 2020 | MIGRA-THERAPEUTICS, LLC | 3175 PRESIDENTIAL DR SUITE B | ATLANTA | GA | 30340-3907 | DEKALB | USA | R41CA247165 | Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents | 001 | 1 | NIH | 9/17/2020 | $105,503 |
| | 2020 | 2020 | MIGRA-THERAPEUTICS, LLC | 3175 PRESIDENTIAL DR SUITE B | ATLANTA | GA | 30340-3907 | DEKALB | USA | R41CA247165 | Tumor Stroma Breaking System for Efficient Delivery of Therapeutic Agents | 000 | 1 | NIH | 6/23/2020 | $224,860 |
|
| Issue Date FY: 2019 ( Subtotal = $224,425 ) |
| | 2019 | 2019 | MIGRA-THERAPEUTICS, LLC | 3175 PRESIDENTIAL DR SUITE B | ATLANTA | GA | 30340-3907 | DEKALB | USA | R43CA246827 | Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy | 000 | 1 | NIH | 9/19/2019 | $224,425 |
|
|
